NCT02452216 2017-08-31
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Stanford University
Phase EARLY_PHASE1 Completed
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Central Nervous System Vascular Malformations × Ferrosoferric Oxide × Clear all